新型コロナウイルス感染症 (COVID-19) ：パイプライン製品の分析
Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H2 2020
|新型コロナウイルス感染症 (COVID-19) ：パイプライン製品の分析|
発行: Global Markets Direct
ページ情報: 英文 3207 Pages
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coronavirus Disease - Pipeline Review, H2 2020, provides an overview of the Coronavirus Disease (Infectious Disease) pipeline landscape.
Coronaviruses are a group of viruses belonging to the family Coronaviridae. These viruses cause respiratory infections ranging from the common cold to severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The most common symptoms are fever, tiredness, and dry cough. The virus is thought to spread mainly from person-to-person who are in close contact with one another and through respiratory droplets produced when an infected person coughs or sneezes.
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Coronavirus Disease - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Coronavirus Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Coronavirus Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Coronavirus Disease 2019 (COVID-19) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 64, 121, 94, 4, 42, 288, 271 and 11 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 1, 7, 5, 1, 69, 69 and 2 molecules, respectively.
Coronavirus Disease (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.